Literature DB >> 25259556

Intrathecal morphine analgesia after cervical and thoracic spinal cord tumor surgery.

Beate Poblete1, Christoph Konrad, Karl F Kothbauer.   

Abstract

OBJECT: The aim of this study was to provide evidence for the effect of intrathecal morphine application after spinal cord tumor resection.
METHODS: Twenty patients participated in a prospective open proof-of-concept study. During dural closure, morphine (7 μg/kg) was injected into the subarachnoid space. All patients were monitored in an intensive care setting postoperatively. Pain, additional opioids given, and vital parameters were recorded.
RESULTS: Six patients received a mean morphine dose of 365 μg between C-3 and C-7 and 14 patients received a mean dose of 436 μg between T-2 and T-12. In the cervical and thoracic groups, the mean Numeric Rating Scale score was highest upon intensive care unit admission (1.2 and 2.5, respectively) and declined at 12 hours (0.5 and 0.8, respectively). Minimal extra morphine was required. Minor side effects occurred without consequence.
CONCLUSIONS: Intrathecal morphine for postoperative analgesia after resection of cervical and thoracic spinal cord tumors is effective and safe. These preliminary results require confirmation by larger comparative studies and further clinical experience.

Entities:  

Keywords:  ICU = intensive care unit; MABP = mean arterial blood pressure; NRS = Numeric Rating Scale; SaO2 = oxygen saturation; analgesia; cervical; oncology; pain; pediatric; spinal cord tumor; thoracic

Mesh:

Substances:

Year:  2014        PMID: 25259556     DOI: 10.3171/2014.8.SPINE1436

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  2 in total

1.  Safety and Efficacy of the Use of Intrathecal Morphine for Spinal Three Column Osteotomy.

Authors:  Jason R Audlin; Swamy Kurra; William Lavelle; Richard A Tallarico; Mike H Sun; Nathaniel R Ordway; Elizabeth A Demers Lavelle
Journal:  Cureus       Date:  2017-11-03

Review 2.  REGIONAL ANESTHESIA FOR NEUROSURGERY.

Authors:  Dinko Tonković; Daniela Bandić Pavlović; Robert Baronica; Igor Virag; Martina Miklić Bublić; Nataša Kovač; Drvar Željko
Journal:  Acta Clin Croat       Date:  2019-06       Impact factor: 0.780

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.